Hutch News

Hutch News

Stories tagged 'anogenital cancers'

Good News at Fred Hutch

Celebrating faculty and staff achievements

June 8, 2017

Fred Hutch epidemiologist Dr. Margaret Madeleine just received a five-year, $2.5 million grant from the National Cancer Institute to test whether the preventive HPV vaccine could be also be used as a therapy anogenital precancers.

View story >

HPV debate reframed to focus on cancer

U.S. cancer centers unanimously call for increase in vaccine use for cancer prevention

Jan. 27, 2016 | By Dr. Rachel Tompa / Fred Hutch News Service

All 69 National Cancer Institute-designated cancer centers are joining together to voice their frustration at the low uptake of the HPV vaccine — with the hope of refocusing the lens of the vaccination discussion on cancer prevention.

View story >

The HPV cancer vaccine: Are two doses as good as three?

A reduced dosing regimen may increase vaccination adherence, decrease costs

Aug. 26, 2014 | By Diane Mapes / Fred Hutch News Service

How do you get more people to take advantage of the cancer-busting HPV vaccine? One way might be to lower the number of doses, a hot topic among public health researchers attending HPV2014, the 29th International Papillomavirus Conference, which came to a close Monday in Seattle.

View story >

(RSS feeds are best viewed in browsers other than Chrome)

Editor's Picks


Support our quest for cures

Story Archive


Magazine Archive
Back issues of Hutch Magazine

Financial Reporting
Fiscal highlights & Annual Reports

Science Spotlight
Monthly review of Center-authored papers

Fred Hutch News

        Get updates via email.